 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
Research
Karin Galil,* Lisa A. Miller,† Mitchell A. Yakrus,* Richard J. Wallace
Jr.,‡ David G. Mosley,§ Bob England,§ Gwen Huitt, ¶ Michael M. McNeil,* and
Bradley A. Perkins*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Colorado
Department of Public Health and Environment, Denver, Colorado, USA; ‡University of
Texas Health Center, Tyler, Texas, USA; §Arizona Department of Health Services, Phoenix,
Arizona, USA; and ¶National Jewish Medical and Research Center, Denver, Colorado, USA
 |
| Back to article Figure 1. Abscesses due to Mycobacterium abscessus on the left hip of 64-year-old man who had injected (numerous times) a presumed adrenal cortex extract. The first lesion developed 9 weeks before this photograph was taken. |
 |
| Back to article Figure 2. Dates of last injection of a presumed adrenal cortex extract among persons who developed postinjection Mycobacterium abscessus abscesses, United States, January 1995 to September 1996. |
 |
| Back to article Figure 3. Dates of abscess onset in persons who had postinjection Mycobacterium abscessus abscesses after using a presumed adrenal cortex extract, United States, January 1995 to September 1996. |
 |
| Back to article Figure 4. Pulsed-field gel electrophoresis patterns of three Mycobacterium abscessus isolates from the outbreak (lanes 1-3), six control isolates (lanes 4-8), and lambda DNA standards (lane 9). The chromosomal DNA was digested with XbaI. |
Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us CDC Home | Search | Health Topics A-Z This page last reviewed July 1, 1999 Emerging Infectious Diseases Journal |